hBUB1 defects in leukemia and lymphoma cells

Area of Science:

• Molecular Biology
• Cancer Genetics
• Cell Biology

Background:

• Tumorigenesis involves genetic alterations, with aneuploidy (abnormal chromosome number) common in malignancies.
• Aneuploidy leads to chromosomal instability (CIN), increasing mutation rates and promoting cancer progression.
• The spindle assembly checkpoint, involving genes like hBUB1, ensures proper chromosome distribution during mitosis.

Purpose of the Study:

• To investigate mutations in the human BUB1 (hBUB1) gene in breast cancer cell lines with and without CIN.
• To identify hBUB1 gene alterations in hematological malignancies associated with aneuploidy.

Main Methods:

• Analysis of hBUB1 gene mutations in breast cancer cell lines.
• Examination of hBUB1 gene coding sequences in T lymphoblastic leukemia, acute lymphoblastic leukemia, and Hodgkin's lymphoma cells.
• Characterization of deletion locations and dominance of mutant hBUB1 cDNA.

Main Results:

• No hBUB1 gene mutations were found in breast cancer cell lines, regardless of CIN status.
• Heterozygous deletions in the hBUB1 gene's kinetochore localization domain were detected in T lymphoblastic leukemia and other leukemia/lymphoma samples.
• The identified deletions in hBUB1, similar to mutations in colorectal cancer, exhibited dominant function.

Conclusions:

• hBUB1 gene deletions, particularly in the kinetochore domain, are associated with aneuploidy in certain hematological malignancies.
• These deletions may contribute to tumorigenesis by disrupting chromosome segregation.
• The dominant nature of these hBUB1 alterations suggests a significant role in cancer development.